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Abstract A disulfide-engineered analogue of bovine pancreatic
trypsin inhibitor (BPTI), ((NK-(CH2)2S-)Gly38)BPTI, has been
prepared using a thioester-mediated auxiliary functional group
chemical ligation of a NK-ethanethiol-containing peptide seg-
ment with a peptide-KCOSR segment. In this study, NK-
(ethanethiol)Gly38 replaces the native Cys38, providing the
sulfhydryl group required for ligation and folding. Comparisons
between ((NK-(CH2)2SH)Gly38)BPTI, synthetic native BPTI
and reference BPTI purchased from Sigma were made using
mass spectroscopy, enzyme inhibitor association constant
determination (Ka) and 1H-nuclear magnetic resonance total
correlated spectroscopy (1H-NMR TOCSY) measurements. The
Ka value for ((NK-(CH2)2SH)Gly38)BPTI was approximately
20-fold lower than synthetic and reference BPTI, which was
attributed to perturbations in the binding loop of the protein
(near Cys14). This hypothesis was confirmed by two-dimensional
(2D) 1H-NMR TOCSY experiments. The data reported here
demonstrate that total chemical synthesis by auxiliary functional
group chemical ligation is a practical method for the synthesis of
a novel class of biologically active protein analogues containing
additional functional groups linked to the protein backbone.
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1. Introduction
Since its introduction in 1994 [1], thioester-mediated amide-
forming chemical ligation of unprotected peptide segments,
termed native chemical ligation, has greatly facilitated the
total synthesis of proteins. Prior to this ligation strategy, the
synthesis of native protein domains was an arduous task,
most often undertaken by stepwise solid phase peptide syn-
thesis methods. With few exceptions, the products of these
syntheses were complex mixtures and were intractable to pu-
ri¢cation to homogeneous molecular preparations. With the
advent of native chemical ligation, the routine synthesis of
small, disul¢de-containing proteins has become a reality [2].
Native chemical ligation requires a cysteine residue at the
ligation site (Fig. 1a) [1]. Despite this limitation, the power of
this technology has been demonstrated by the successful syn-
thesis of biologically active proteins including a variety of
chemokines such as interleukin-8 [1] and SDF1K [3], bovine
pancreatic trypsin inhibitor (BPTI) [4], turkey ovomucoid
third domain [5] and barnase [6]. Nonetheless, it would be
of considerable utility to surmount the necessity for a cysteine
residue at the ligation site.
A possible route for generalization to native chemical liga-
tion at amino acids other than cysteine would be to separate
the thiol moiety required for ligation from the functionality of
the side-chain of the amino acid in the reacting peptide seg-
ment. Recently, Canne et al. [7] reported a ligation at Gly-Gly
residues accomplished by employing a removable NK-linked
auxiliary thiol moiety to provide the functionality required in
the ligation reaction. In the course of that study, an extremely
facile chemical ligation reaction was observed utilizing a non-
removable NK-ethanethiol auxiliary functional group (Fig.
1b). The product of this ligation reaction contains a peptido-
mimetic backbone structure at the ligation site, a NK-(ethane-
thiol) amide.
It occurred to us that use of a NK-(ethanethiol)glycine res-
idue to replace a cysteine involved in disul¢de bond formation
would result in a novel type of engineered protein (Fig. 1c).
To our knowledge, the properties of such a NK to side-chain
disul¢de bond have not been explored in the context of a
protein molecule.
We chose BPTI (Fig. 2) as a model system in which to
establish the use of the NK-(ethanethiol) auxiliary functional
group in the total chemical synthesis of a protein and to
examine the properties of the resulting disul¢de-engineered
protein. BPTI is probably the most intensively studied protein
extant and contains a Gly37-Cys38 site appropriate for native
chemical ligation. It is a small (6.5 kDa) protein ¢rst identi¢ed
in 1936 because of its remarkable thermal stability and ability
to strongly inhibit trypsin [8]. BPTI possesses 58 amino acids,
six of them cysteine residues that form three disul¢de bonds in
the folded structure. The cysteine pairings are residues 5^51,
14^38 and 30^55 [9]. The three-dimensional (3D) structure of
this protein has been solved both crystallographically [10] and
by nuclear magnetic resonance (NMR) spectroscopy [11,12].
In addition, BPTI has a well-documented folding behavior
[13,14]. Furthermore, this protein has previously been pre-
pared in our laboratory by total synthesis using native chem-
ical ligation [4].
Here, we report the use of the non-removable auxiliary
functional group, NK-(ethanethiol), in the synthesis of a bio-
logically active, disul¢de-engineered BPTI, ((NK(CH2)2SH)-
Gly38)BPTI. In this BPTI analogue, Cys38 has been replaced
by a NK-(ethylthiol)Gly38 residue. The chemically synthesized
polypeptide folded to give a functional protein containing
three disul¢de bonds. The properties of this analogue were
compared to native BPTI synthesized by chemical ligation
and to a reference sample of native BPTI purchased from
Sigma. These comparisons included electrospray mass spec-
trometry (ESMS), association constant binding studies (Ka)
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Fig. 1. Amide-forming ligation reactions: (a) native chemical ligation [1], (b) ligation using a NK-(ethanethiol)glycine auxiliary functional group
[7], (c) disul¢de engineering using the NK-ethanethiol auxiliary functional group. The disul¢de-engineered system has an extra methylene in the
disul¢de linkage and the connection to the backbone has been shifted from the CK to the amide nitrogen; the amino acid side-chain has been
deleted.
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with chymotrypsin and a detailed comparison of the ¢nger-
print regions of the homonuclear two-dimensional (2D) 1H-
total correlated NMR spectroscopy (2D 1H-NMR TOCSY)
experiments. While all three of these BPTI proteins are potent
inhibitors of both chymotrypsin and trypsin, the Ka of
((NK(CH2)2SH)Gly38)BPTI with chymotrypsin was found to
be 20-fold less than the a⁄nity of the native protein, which
suggested a perturbation in the binding loop of the BPTI
analogue. This interpretation was con¢rmed by the ¢ngerprint
regions of the 2D-TOCSY spectra. These data unequivocally
demonstrate the feasibility of auxiliary functional group
chemical ligation in the synthesis of biologically active pro-
teins and open protein design and engineering to modi¢ca-
tions previously demonstrated only for smaller peptidomimet-
ics [15,16].
2. Materials and methods
For £ash-column chromatography of organic compounds, silica gel
(230^400 mesh) was used in standard glass columns with gravity or air
pressure. Analytical reversed phase high performance liquid chroma-
tography (HPLC) was performed on a Rainin HPLC system with UV-
detection at 214 nm using a Vydac C-18 analytical (5 Wm, 0.46U15
cm) column. Semi-preparative reversed phase HPLC was performed
on a Rainin HPLC system with UV-detection at 230 nm using a
Waters RCM 8U10 module equipped with a Delta Pack C-18 Radial
Pack cartridge (15 Wm, 8U100 mm) column from Millipore. Prepara-
tive scale reversed phase HPLC was performed on a Waters Delta
Prep 4000 system with UV-detection at 230 nm using a Vydac C-18
preparative (15^20 Wm, 5.0U25 cm) column. Linear gradients of
bu¡er B in bu¡er A (A = 0.1% tri£uoroacetic acid (TFA) in water,
B = 0.09% TFA in 90% acetonitrile/10% water) were used for chroma-
tographic separations. Flow rates were 1 ml/min for analytical, 4 ml/
min for semi-preparative and 30 ml/min for preparative scale HPLC.
A⁄nity chromatography was performed on an anhydro-trypsin solid
support resin in a Flex column. Adsorption solvent was 20 mM MES
at pH 6.0. Non-speci¢cally bound protein was eluted in 200 mM NaCl
and the speci¢cally bound protein was eluted in 200 mM NaCl with
100 mM HCl. Desalting was performed using 1% acetic acid in water
with a Sephadex G-25 gel ¢ltration column. All mass spectra of pep-
tides and proteins were obtained on a Sciex API-III electrospray ion-
ization triple-quadrupole mass spectrometer. The observed masses
reported were derived from the experimental m/z states for all ob-
served charge states of a molecular species, using the program Mac-
Spec (Sciex, version 2.4.1). Calculated masses reported were derived
from the program MacProMass (Terry Lee and Sunil Vemuri, Beck-
man Research Institute, Duarte, CA, USA) and re£ect the average
isotope composition. Phase sensitive 2D 1H-NMR TOCSY spectra
were recorded on a Brucker AMX 500 spectrometer using Watergate
solvent suppression [21,27]. Ultraviolet-visible (UV-vis) spectroscopy
was performed on a Hewlett-Packard 8452A photodiode array spec-
trophotometer. Boc-L-amino acids were purchased from Nova-
biochem (La Jolla, CA, USA) and Bachem Biosience (King of Prus-
sia, PA, USA). 2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium
hexa£uorophosphate (HBTU) was purchased from Richelieu Biotech-
nologies (Montreal, Canada). Boc-Ala-OCH2-Pam-resin and diisopro-
pylethylamine (DIEA) were purchased from Applied Biosystems (Fos-
ter City, CA, USA) and methylbenzhydrylamine (MBHA) resin was
purchased from Peninsula Laboratories (San Carlos, CA, USA). JT-
Baker Photrex grade dimethylformamide (DMF) and Baker Analyzed
acetonitrile were obtained from Baker. HPLC grade methylene chlor-
ide (CH2Cl2) was purchased from Fisher. TFA was purchased from
Halocarbon (New Jersey). Anhydrous hydrogen £uoride (HF) was
purchased from Matheson Gas. Flex columns were purchased from
Fisher Scienti¢c (Tustin, CA, USA). Silica gel (230^400) mesh was
purchased from Aldrich (Milwaukee, WI, USA). Sephadex G-25 was
purchased from Pharmacia Biotech (Piscataway, NJ, USA). All other
reagents were of analytical reagent grade or better and purchased
from Aldrich (Milwaukee, WI, USA) or Lancaster (Windham, NH,
USA).
2.1. Peptide segment synthesis
Synthesis of peptides was carried out manually by established meth-
ods using in situ neutralization and HBTU activation procedures for
stepwise Boc chemistry solid phase peptide synthesis [18]. Synthesis
was performed on either Boc-Ala-OCH2-Pam-resin or Boc-Gly-thio-
ester-resin. Boc-Gly-thioester-resin was prepared by coupling (4-((NK-
t-Boc-Gly-S)benzyl)phenoxy)-acetic acid, dicyclohexylamine salt
(2.0 equivalents), to aminomethyl resin (one equivalent, washed with
10% DIEA in DMF) with HBTU (1.6 equivalents) added as an
activating agent and DIEA (one equivalent) in DMF [28]. Protection
of amino acid side-chain functional groups was as follows: Boc-
Arg(p-toluenesulfonyl)-OH, Boc-Asn(xanthyl)-OH, Boc-Asp(O-cyclo-
hexyl)-OH, Boc-His(dinitrophenyl)-OH, Boc-Thr(benzyl)-OH, Boc-
Tyr(2-bromobenzyloxy-carbonyl)-OH, Boc-Cys(4-methylbenzyl)-OH,
Boc-Glu(O-cyclohexyl)-OH, Boc-Lys(2-Cl-Z)-OH and Boc-Ser(ben-
zyl)-OH. Other amino acids required no side-chain protection. Cou-
pling was monitored by a quantitative ninhydrin assay after 10 min
coupling cycles (typical coupling yields were s 99%). After chain
assembly, the NKBoc group was removed with neat TFA (two 1 min
treatments), the salt of the peptide-resin was neutralized with 10%
DIEA in DMF (two 1 min treatments), then, NK-deprotected pep-
tide-resin was washed with DCM and dried in vacuo for s 30 min.
The peptides were simultaneously deprotected and cleaved from the
resin support with anhydrous HF containing either 10% p-cresol or
10% anisole at 0‡C for 1 h to yield the deprotected peptide-KCOSH or
-KCO2H. Removal of HF was accomplished over 5^10 min under
reduced pressure and the crude peptide was triturated with diethyl
ether, dissolved in HPLC bu¡er (60% B), diluted to 6 20% acetoni-
trile by volume and lyophilized.
2.2. BPTI(1^37)-K thioester (1)
BPTI(1^37)-Kacyl thioester was generated by reaction of the crude
cleaved BPTI(1^37)-KCOSH thioacid with s 10 equivalents of 2-bro-
moacetic acid in 2 ml 6 M GnHCl, 100 mM sodium acetate, pH = 4.0
for 120 min at room temperature. The Kthioester product was isolated
by preparative HPLC (20^55% B in 60 min) in a 10% yield in respect
to the crude HF-cleaved peptide. The identity of BPTI(1^37)-Kacyl
thioester (1) was con¢rmed by electrospray mass spectroscopy (ob-
served mass 4291.5 þ 0.5 Da, calculated mass 4291.0 Da average iso-
tope distribution).
2.3. BPTI ((NK (CH2)2SH)Gly38)(38^58)-KCO2H peptide (2a)
BPTI(39^58)-KCO2H was synthesized on Boc-Ala-OCH2-Pam-res-
in. After completion of chain assembly, the NKBoc protecting group
was removed by TFA treatment (two 1 min treatments with neat
TFA). The peptide was then bromoacetylated by the Robey method
[29]. Bromoacetic acid (236 mg, 2.0 mmol) was dissolved in CH2Cl2
(2 ml) and diisopropylcarbodiimide (156 Wl, 1.0 mmol) was added.
The solution turned cloudy with a £oting precipitate. After activation
for 15 min to form the symmetric anhydride, DMF (2 ml) was added
and the resulting turbid solution was added to the deprotected pep-
tide-resin and coupled for 20 min. The resin was washed with two 30 s
£ow washes of DMF and then a batch wash of DMSO. The DMSO-
saturated BrAc-peptide-resin was then reacted with a 2 M solution of
S-(4-methylbenzyl)-2-aminoethanethiol (181 mg, 1.0 mmol) in 300 Wl
DMSO and 200 Wl DIEA for 14 h [7]. The resin was washed with two
Fig. 2. Ribbon diagram of native BPTI. Positions of the disul¢des
(between cysteines 14^38, 30^51 and 5^55) are shown in lighter
shade. The site of modi¢cation using the NK-ethanethiol auxiliary
functional group is at Cys38 on the sca¡old loop.
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30 s DMF £ow washes, rinsed well with DCM/MeOH (1:1 v/v) and
dried in vacuo for s 30 min. Standard HF cleavage was performed
with p-cresol as the scavenger. ((NK(CH2)2SH)Gly38)BPTI(38^58)-
KCO2H, peptide (2a), was puri¢ed by preparative HPLC (10^40% B
in 45 min) in 30% yield from the crude HF-cleaved peptide (observed
mass 2331.0 þ 0.5 Da, calculated mass 2331.7 Da average isotope dis-
tribution).
2.4. BPTI(38^58)-KCO2H peptide (2b)
BPTI(38^58)-KCO2H peptide (2b) was synthesized in the same man-
ner as BPTI(39^58)-KCO2H, incorporating a cysteine at position 38
(observed mass, calculated mass 2318.7 Da average isotope distribu-
tion).
2.5. Chemical ligations
Ligation reactions were performed in 6 M GnHCl, 100 mM phos-
phate, pH 7.5, at concentrations of 8^10 mg/ml for each peptide.
Thiophenol (2^4% by volume) was added to maintain a reducing
environment and accelerate the ligation reaction by exchanging the
peptide-Kthioacyl ester to the peptide-Kthiophenyl ester [19]. The liga-
tion reaction proceeded rapidly with signi¢cant product formation
after 1^2 h. The clear reaction solution became progressively more
cloudy with a white precipitate forming during the course of the
ligation. To guarantee the completion of the reaction, ligations were
allowed to react for 16^24 h prior to quenching with 20^40 mg di-
thiothreitol (DTT), mixing for 20 s and then letting the solution stand
at room temperature for 30^45 min. The milky precipitate gradually
dissolved into solution during this time. The ligation product was then
puri¢ed by semi-preparative reversed phase HPLC (20^55% B in
45 min).
2.6. ((NK(CH2)2SH)Gly38)BPTI ligation (Fig. 4) [7]
15 mg BPTI(1^37)KCOSCH2CO2H (1) (observed mass 4291.5 þ 0.5
Da, calculated mass 4291.9) and 15 mg BPTI ((NK(CH2)2SH)-
Gly38)(38^58)-KCO2H (2a) (observed mass 2331.0, calculated mass
2331.7) were dissolved in 2 ml of 6 M GnHCl, 100 mM phosphate,
pH 7.5. After 5 Wl of this solution was used for a zero time point
HPLC analysis, thiophenol was added (4% by volume). The reaction
was mixed for 20 s and was then left standing at room temperature for
14 h. The reaction was monitored by analytical HPLC analysis at
various time points (Fig. 4). BPTI(1^37)-KCOSCH2CO2H (1) disap-
peared rapidly after thiophenol was added and the thioester exchange
product [6], BPTI(1^37)KCOSC6H5 (observed mass 4323.5 þ 0.5 Da,
calculated mass 4323.9), co-eluted with thiophenol under the chroma-
tography conditions used. After 14 h, the ligated product,
((NK(CH2)2SH)Gly38)BPTI (observed mass 6530.0 þ 0.5 Da, calcu-
lated mass 6530.6 average isotope distribution), was recovered from
the DTT-quenched reaction by semi-preparative reversed phase
HPLC (20^55% B in 45 min, elution time 19 min) and lyophilized
to yield 9 mg of pure unfolded ((NK(CH2)2SH)Gly38)BPTI (40%).
2.7. BPTI native ligation [1]
15 mg of BPTI(1^37)-KCOSCH2CO2H (1) (observed mass
4291.5 þ 0.5 Da, calculated mass 4291.9 average isotope distribution)
and 15 mg of BPTI(38^58)-KCO2H (2b) (observed mass 2318.3 þ 0.5
Da, calculated mass 2318.7 average isotope distribution) were dis-
solved in 2 ml of 6 M GnHCl, 100 mM phosphate, pH 7.5. After a
5 Wl aliquot was removed for HPLC analysis, thiophenol (4% by
volume) was added. The reaction was mixed brie£y for 20 s and
was then left standing at room temperature. During the course of
the reaction, the solution became increasingly opaque with a white,
cloudy precipitate. After 16 h, the reaction was quenched for 40 min
with 20^40 mg DTT and the product, native BPTI, was puri¢ed by
semi-preparative HPLC (20^55% B in 45 min, elution time 19 min)
and lyophilized to yield 9 mg of pure unfolded native BPTI (40%
yield) (observed mass 6516.0 þ 1.0 Da, calculated mass 6517.6 average
isotope distribution).
2.8. Folding [1]
Pure unfolded synthetic BPTI (9 mg) or ((NK(CH2)2SH)Gly38)BPTI
(9 mg) was dissolved in 1 ml of 6 M GnHCl, 100 mM phosphate, pH
7.5. When the solution was complete, 49 ml of ¢ltered water was
rapidly added and the resulting solution mixed brie£y. The concen-
tration of folding protein is critical and should not exceed 0.3 mg/ml
to reduce the chances of non-speci¢c aggregation and precipitation.
The reaction was left standing at room temperature overnight, vented
to the atmosphere to permit air oxidation. The total crude folded
protein preparations were subjected to a⁄nity chromatography to
recover active folded protein.
2.9. A⁄nity chromatography [20]
Solutions of folded synthetic native BPTI and ((NK(CH2)2SH)-
Gly38)BPTI were bound to an anhydro-trypsin a⁄nity column equi-
librated in 20 mM MES, pH 6.0 bu¡er. After loading the sample onto
the column, the column was washed with the equilibration bu¡er.
When a stable base line was obtained, the column was then washed
with 0.2 N NaCl in water to elute non-speci¢cally bound folding by-
products. Again, after a stable base line was obtained, the desired
native BPTI or folded ((NK(CH2)2SH)Gly38)BPTI protein was eluted
with 0.2 N NaCl in 0.1 N HCl. In a number of cases, the elution of
protein from the a⁄nity column resulted in two peaks that were not
completely separable (these peaks were isolated and later demon-
strated the same behavior in the Ka assay and mass spectrometry).
This occurred with both proteins and is most likely the result of
incomplete solubility in the low pH-high salt elution bu¡er. The
eluted protein was diluted with an equal volume of ¢ltered water
and lyophilized.
2.10. Desalting
Proteins eluted from the a⁄nity column contained considerable
quantities of NaCl. The native BPTI or folded ((NK(CH2)2SH)-
Gly38)BPTI was desalted using a Sephadex G-25 gel ¢ltration column
with a 1% acetic acid elution solvent. The eluted proteins were lyophi-
lized to yield folded native BPTI (4 mg, 44% yield, observed mass
6511.3 Da, calculated mass 6511.6 Da average isotope distribution)
and folded ((NK(CH2)2SH)Gly38)BPTI (3.7 mg, 41% yield, observed
mass 6525.0, calculated mass 6525.5 average isotope distribution).
2.11. S-(4-Methylbenzyl)-2-aminoethane thiol
2-Aminoethane thiol (500 mg, 6.5 mmol) was dissolved in dry THF
(10 ml) and DIEA (1.0 ml) and 0.75 equivalent 4-methylbenzyl bro-
mide (906 mg, 4.9 mmol) was added to this solution while stirring at
room temperature. After 6 h, the solvent was removed in vacuo and
the resulting oil was puri¢ed by £ash-column chromatography with a
gradient of 1^10% methanol in chloroform to yield A as an oily solid
(621 mg, 70% yield). Rf = 0.15^0.3 streak in 5% MeOH in chloroform,
UV and ninhydrin active. 1H-NMR (CDCl3) N 1.45 (s, 2H), 2.32 (s,
3H), 2.5 (t, J = 6.2Hz, 2H), 2.8 (t, J = 6.2 Hz, 2H), 3.66 (s, 2H), 7.14
(dd, J = 7.97 Hz, 24.0 Hz, 4H). FAB-MS for (C10H15NS-H) observed
182.1003 Da, calculated 182.1005 Da.
2.12. Chromogenic substrates [19]
The chromogenic substrates, Suc-GGF-pNa and Bz-VGR-pNa,
were dissolved in 20 mM CaCl2 with 2 mM HCl to a ¢nal concen-
tration of 25 mg/ml. These solutions were used directly and were
stable at room temperature in the dark for several months.
2.13. Standardization of BPTI solutions [19]
All BPTI stock solutions were dissolved at a concentration of 1 mg/
ml in water with 20 mM CaCl2 and 2 mM HCl. These BPTI stock
solutions were diluted, one part stock solution/three parts water, prior
to use. Two Wl of 1 mg/ml trypsin dissolved in 20 mM CaCl2 and
2 mM HCl was added to 3 ml of assay bu¡er (0.1 M Tris-HCl,
20 mM CaCl2, 0.005% Triton X-100, pH 8.3) in a disposable cuvette.
To this solution was added 0, 2, 4 and 6 Wl of a solution of either
((NK(CH2)2SH)Gly38)BPTI, synthetic native BPTI or purchased na-
tive BPTI and the solution was mixed. The trypsin/inhibitor solution
was incubated for 12 min at 23‡C prior to adding 5 Wl of a 25 mg/ml
solution of the chromogenic substrate benzyl-VGR-pNa. After mixing
for 5 s, the rate of cleavage of the chromogenic substrate was followed
by UV-vis spectroscopy with average absorbance monitoring between
380 and 410 nm for 60 s at one measurement per second. The data
were graphed and ¢tted to a line using least squares analysis. The
volume required for complete inhibition was extrapolated and the
concentration was determined assuming a trypsin/inhibitor stoichiom-
etry of 1:1. In some cases, signi¢cant curvature of the ¢tted data was
noted and further dilutions (1:10) of the inhibitor were required to
obtain a linear response.
Another method for analysis of the concentration of protein in
solution was proposed by Waddell [30]. This method uses UV-vis
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spectroscopy to determine the concentration of protein solution by the
formula:
A2143A224U144  C
where C is the concentration of protein in Wg/ml. The range of accu-
racy for this method is between 10 and 100 Wg/ml. Because all proteins
in the stock solutions should be active inhibitors of trypsin, the titra-
tion and Waddell method should yield similar values of the protein
concentration.
2.14. Association constant determination [19]
5 Wl of a 4 mg/ml solution of chymotrypsin (Eo = 2.67U1037 M
¢nal concentration) was dissolved in 3 ml of assay bu¡er (0.1 M
Tris-HCl, 20 mM CaCl2, 0.005% Triton X-100, pH 8.3). To this
solution was added a solution of either ((NK(CH2)2SH)Gly38)BPTI,
synthetic native BPTI or native BPTI purchased from Sigma in the
appropriate volumes for ¢nal concentrations of inhibitor ranging from
0.534U1038 to 5.34U1037 M in 10 steps (0.2Eo32Eo in 10 steps).
The chymotrypsin-inhibitor mixture was incubated at 23‡C for 5 min
prior to adding 10 Wl of a 25 mg/ml solution of the chromogenic
substrate Suc-GGF-pNA. After mixing for 5 s, the rate of cleavage
of the pNa substrate was followed by UV-vis spectroscopy with aver-
age absorbance monitoring at 380^410 nm over 120 s with a cycle
time of 1 s and an integration time of 0.5 s. The derivation of the
association constant, Ka, is derived from the equation:
Ka  EI =EUI   Eo3E=EUIo3Eo  E 1
where [E], [I] and [EI] are the equilibrium concentrations of enzyme,
inhibitor and enzyme-inhibitor complex and [Eo] and [Io] are the total
concentrations of enzyme and inhibitor. Eq. 1 is quadratic and has a
physically meaningful root:




The solution to Eq. 1 can be calculated directly by two- or three-
parameter non-linear least squares ¢tting procedures with the caveat
that the three-parameter ¢tting is not valid for Ka values of less than
1U106. This caveat is a function of the assay itself. For a valid
measurement of Ka by three-parameter ¢t, KaUEo must be between
¢ve and 30. If this value is s 30, the determined Ka will depend
greatly on the last few data points which are inherently noisy. If
KaUEo is 6 5, the inhibition reaction may not proceed stoichiometri-
cally and three-parameter ¢tting is not valid [20].
The calculation for Ka can also be done at each inhibitor concen-
tration as the slope of the reaction has a linear relationship to the
quantity of free enzyme in the reaction (and, therefore, is a direct
measurement of [E]). The ratio of the slope for the reaction at the
inhibitor concentration [Io], and the reaction without inhibitor, yields
a percentage value of the remaining free enzyme in solution. Multi-
plying this percentage by [Eo] is a direct measure of [E] at equilibrium
at that inhibitor concentration [Io]. In combination, there are 11 in-
dependent measurements of Ka in each experiment.
2.15. 2D 1H-NMR spectroscopy
Protein samples were dissolved in 500 Wl of 90% Millipore ¢ltered
water, 10% D2O (99.9% deuterium) with the pH adjusted to 4.6 with
minute amounts of HCl. Actual quantities of protein in solution were
3.8 mg for ((NK(CH2)2SH)Gly38)BPTI, 6.8 mg for synthetic native
BPTI and 5.1 mg for Sigma BPTI as determined by trypsin titration.
The spectra were recorded on a Brucker AMX 500 NMR spectrom-
eter at 23‡C using a modi¢ed Brucker 2D 1H-TOCSY pulse sequence
[21]. Solvent signal suppression during acquisition was accomplished
using the Watergate pulse sequence [27]. Data were accumulated over
6^12 h and processed using FELIX NMR software from Molecular
Simulations (San Diego, CA, USA). Sequence assignments for these
spectra were obtained by direct comparison with literature COSY
spectra and assignment tables [11,12,22]. The spectra for the three
proteins were then compared in the following regions: (1) CK-NH
amide (g2 = 10.5^6.5 parts per million (ppm), g1 = 5.6^3.0 ppm), (2)
Ala CK-CL/Thr CQ -CL proton (g2 = 2.0^0.5 ppm, g1 = 5.8^3.0 ppm)
and (3) aromatic proton (g2 =g1 = 8.0^6.0 ppm).
3. Results
3.1. Experimental design
The sequence of BPTI (Fig. 3) reveals a convenient native
ligation site at Gly37-Cys38 that was utilized in a previous
synthesis of this protein [4]. Use of the NK-(ethanethiol)Gly38
auxiliary functional group for the synthesis of BPTI at this
ligation site would generate a modi¢ed backbone structure
(Fig. 1c). While Cys38 forms a disul¢de bridge with Cys14 in
the folded protein (Fig. 2), it has previously been found that
variants of BPTI in which Cys38 was mutated to alternate
amino acids, thus preventing disul¢de formation, showed re-
tention of the 3D structure and possessed a signi¢cant bio-
Fig. 3. Strategy used for the synthesis of the engineered protein corresponding to ((NK(CH2)2SH)G38)BPTI (1+2a) and and for the synthesis of
native BPTI (1+2b). Amino acids at the site of ligation are in bold and underlined.
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logical activity [17]. These data suggested to us that this pro-
tein was amenable to auxiliary functional group ligation and
would tolerate the NK-ethanethiol structural modi¢cation at
the ligation site with a high probability of forming a func-
tional, disul¢de-crosslinked molecule.
The ligation strategy for the synthesis of both the native
and disul¢de-engineered BPTI proteins is outlined in Fig. 3.
All peptide segments were synthesized by optimized in situ
neutralization protocols for Boc chemistry stepwise solid
phase peptide synthesis [18]. To generate the NK-modi¢ed
C-terminal peptide segment, ((NK-(CH2)2SH))-Gly38)BPTI-
(38^58)-KCO2H (2a), the resin-bound peptide BPTI(39^58)
was further derivatized by bromoacetylation followed by dis-
placement of the bromine using S-4-(methylbenzyl) protected
aminoethane thiol as previously reported [7].
Electrospray ionization mass spectrometry was used to
characterize the synthetic 58 residue polypeptide, before and
after folding/disul¢de formation. NMR spectroscopy and as-
sociation constant determination (Ka) of the folded protein
molecule were used to determine the e¡ects of the NK-ethane-
thiol backbone modi¢cation on the protein structure and
function.
3.2. Ligation of BPTI fragments
The auxiliary functional group ligation of the BPTI(1^37)-
KCOSR and ((NK(CH2)2SH)-Gly38)BPTI(38^58)-KCO2H pep-
tide segments proceeded in a rapid manner (Fig. 4) and was
indistinguishable from standard native chemical ligation at
cysteine both in rate and yield. The ligations were allowed
to proceed at pH 7 in aqueous solution containing 6 M gua-
nidine hydrochloride for 16^24 h to ensure complete reaction.
Little or no starting N-terminal BPTI(1^37)-KCOSC6H5 frag-
ment was detectable after 8 h.
3.3. Folding the synthetic BPTI and ((NK(CH2)2SH)Gly38)-
BPTI proteins
Throughout ligation, folding and puri¢cation processes re-
quired to obtain these proteins, no discernible di¡erence
in behavior was noted. The folding e⁄ciency was compar-
able and the correct number of disul¢des formed was as in-
dicated by ESMS (Fig. 5) and a negative DTNB test. While
thermal stability studies have not yet been undertaken,
((NK(CH2)2SH)Gly38)BPTI retained a high degree of chemical
shift dispersion in a 2D 1H-COSY experiment at 68‡C (data
not shown), which indicates retention of the folded structure
at this temperature, in keeping with a high thermostability for
this protein.
3.4. Standardization of BPTI solutions by trypsin titration
[19]
BPTI stock solutions were made by dissolving desalted and
lyophilized native protein (0.63 mg), Sigma BPTI (1.0 mg) and
((NK(CH2)2SH)Gly38)BPTI (0.55 mg) in a solution of 20 mM
CaCl2 and 2 mM HCl to a concentration of 1 mg/ml. Native
BPTI and Sigma BPTI stock solutions were diluted 10-fold
with a 20 mM CaCl2 and 2 mM HCl aqueous solution and
titrated against trypsin to yield active protein concentrations
of 0.68 (synthetic) and 0.51 mg/ml (Sigma). ((NK(CH2)2SH)-
Gly38)BPTI stock solution was diluted 4-fold with CaCl2/HCl
solution and titrated against trypsin to yield an active protein
concentration of 0.38 mg/ml. These concentrations are cor-
rected for dilution and are in excellent agreement with Wad-
del’s method [20].
3.5. Association constant (Ka) determination [19]
The association constants of synthetic BPTI, native BPTI
from Sigma and ((NK(CH2)2SH)Gly38)BPTI for K-chymotryp-
sin were calculated by determining the quantity of free enzyme
in solution in the presence of variable concentrations of in-
hibitor. The results are reported in Table 1. For each addition
of inhibitor, the initial concentrations of inhibitor [Io] and K-
chymotrypsin [Eo] were known. Ka for each independent
measurement was calculated as were the average and S.D.
K-Chymotrypsin was used in these experiments to determine
the relative activities of the three BPTI preparations because
of the experimental di⁄culty of measuring the very strong
BPTI-trypsin interaction.
Initial experiments with ((NK(CH2)2SH)Gly38)BPTI did not
meet the 50% criteria for valid Ka measurements (see Section
2), but all values obtained were consistent. Subsequent anal-
yses with initial inhibitor concentrations of 1[Eo] to 5[Eo] re-
sulted in only 63% inhibition at 5[Eo], but all Ka values
obtained were in excellent agreement with one another and
with the previous experiments, thus satisfying validity con-
straints. Three-parameter ¢tting could not be used for
((NK(CH2)2SH)Gly38)BPTI because the measured Ka is less
than 106. The analyses of the native BPTI prepared by chem-
ical ligation and the native BPTI from Sigma demonstrated
Ka values 20-fold greater than the NK-(ethanethiol) disul¢de-
engineered BPTI variant.
3.6. 2D 1H-NMR spectroscopy
2D 1H-NMR TOCSY (1H-TOCSY) experiments [21] were
used as an indicator of the folded 3D structure and as a gauge
of the similarities between the proteins. Four regions of the
spectra were analyzed: backbone, Val/Leu/Ile methyls, Ala/
Fig. 4. Ligation of BPTI(1^37)-COSCH2C6H5 with ((NK(CH2)2SH)-
Gly38)BPTI(38^58)-COOH. HPLC analyses shown are for the reac-
tion mixture immediately prior to the addition of thiophenol and
after 7 h. The phenyl thioester BPTI(1^37)-COSC6H5 co-elutes with
free thiophenol under the conditions used. Ligations were performed
in 100 mM phosphate bu¡er, 6 M GnHCl at pH 7.5 with 2^4%
(v/v) added thiophenol as catalyst [6].
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Thr methyls and aromatic ring protons. Each protein ana-
lyzed exhibited a high degree of dispersion in all four TOCSY
¢ngerprint regions, indicating a folded 3D protein structure.
The backbone CK-amide ¢ngerprint region provides informa-
tion about the backbone conformations. The other three ¢n-
gerprint regions provide conformational information about
the interior packing of the protein. After a number of se-
quence speci¢c assignments were made for the spectra of na-
tive BPTI with the aid of published regions of COSY spectra
[11,12] and assignment charts [22], the CK-NH, Ala CK-CL/Thr
CQ -CL proton and aromatic proton ¢ngerprint regions were
speci¢cally analyzed between the spectra. These three ¢nger-
print regions for synthetic and native BPTI were essentially
identical to within the error of the experiment ( þ 0.05 ppm in
g1 and g2, Fig. 6a,b).
While direct comparison between the assigned native BPTI
spectra and the spectra for ((NK(CH2)2SH)Gly38)BPTI dem-
onstrates a high degree of conservation of the core structure
of the modi¢ed protein, localized deviations were evident and
were concentrated in the region of the NK-ethanethiol modi-
¢cation. The ¢rst region of di¡erence that can be readily ob-
served is in the vicinity of Cys38 in the CK-amide ¢ngerprint
region (Fig. 6a). No amide signal was evident in the
((NK(CH2)2SH)Gly38)BPTI spectrum, simply because there is
no amide proton at this amino acid. The NK-ethanethiol func-
tional group has replaced the amide proton of this residue.
The perturbation of another local environment can readily be
documented by observing the shifted resonances for the bind-
ing loop protons (Fig. 6a,b). In the direct comparison of the
aromatic, methyl, L- and Q-proton spectral regions between all
three of the BPTI proteins, a high correspondence was found
in the chemical shifts for the side-chain protons (data not
shown). This is a strong indication of similar packing of the
side-chains in the interior of the protein and corroborates the
conservation of the core structure of the protein. Again, the
main spectral di¡erences were concentrated in the regions
near the site of the NK-ethanethiol modi¢cation.
4. Discussion
In 1996, Canne et al. [7] reported the use of auxiliary func-
tional groups for the ligation of model peptide fragments at
sites other than Xxx-Cys. The present work extends these
studies and demonstrates chemical ligation based on the use
of auxiliary functional groups for the synthesis of a ‘disul¢de-
Fig. 5. Electrospray ionization mass spectrometry characterization of synthetic preparations before and after folding and disul¢de formation.
Note the change in charge distribution. Folded proteins have fewer sites that can acquire a proton.
Table 1
Synthetic BPTI ((NK(CH2)2SH)G38) BPTI





Average (U107) 1.68 þ 0.16 0.078 þ 0.012
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engineered’ analogue of BPTI, ((NK(CH2)2SH)Gly38)BPTI.
The auxiliary functional group used in this study, NK-ethane-
thiol, cannot be removed after ligation. This results in a prod-
uct containing an ethanethiol-decorated amide bond at the
ligation site (Fig. 1b). This peptidomimetic permutation was
utilized to form a disul¢de-engineered variant of BPTI with
the objective of determining the synthetic feasibility and the
structural and functional properties of the resulting unnatural
protein.
The synthesis of native BPTI and ((NK(CH2)2SH)-
Gly38)BPTI proved to be very similar. During the course of
the ligation, folding and puri¢cation of both proteins, no sig-
ni¢cant di¡erence in physical chemical behavior was observed.
Folding proceeded under air oxidation with the appropriate
number of disul¢des formed as indicated by ESMS and a
negative DTNB test. Each BPTI variant proved to be a potent
inhibitor of trypsin, which further indicated a functional
folded structure.
Only upon more detailed analysis was a functional di¡er-
ence between the native BPTI synthesized by chemical ligation
at Cys38 and the ((NK(CH2)2SH)Gly38)BPTI detected. Deter-
mination of the association constant (Ka) with K-chymotryp-
sin for native and disul¢de-engineered BPTI variants demon-
strated a 20-fold weaker binding for the engineered protein.
An alteration of binding a⁄nity of this magnitude could not
easily be detected for the interaction of this protein with tryp-
sin because of the extraordinary strength of the trypsin-BPTI
interaction [19,23]. These binding data suggested that a struc-
tural di¡erence existed in the binding loop region of
((NK(CH2)2SH)Gly38)BPTI compared to native BPTI.
A direct corroboration of the structural perturbation in the
binding loop region of ((NK(CH2)2SH)Gly38)BPTI compared
to synthetic native BPTI was obtained by comparison of the
¢ngerprint regions of the 2D 1H-TOCSY NMR spectra.
These spectra clearly demonstrated a nearly identical 3D
structure for the core regions of these two proteins as evi-
denced by the nearly identical chemical shifts for core amide
protons (Fig. 6a,b). The regions of dissimilar chemical shifts
were con¢ned to the residues near the NK-ethanethiol moiety
in ((NK(CH2)2SH)Gly38)BPTI and, not surprisingly, in the
binding loop (residues 8^13) which is attached to the NK-
(ethanethiol)Gly38 by a disul¢de bond to Cys14. Chemical
shifts for the amide protons of the loop residues 10^13 deviate
signi¢cantly from those in the native protein (Fig. 6b). The
signi¢cance of these di¡erences can be readily seen when
mapped onto the known 3D structure of native BPTI (Fig.
7).
Both Ka and 2D 1H-TOCSY NMR data demonstrate that
signi¢cant di¡erences exist between the native and disul¢de-
engineered BPTI protein within the residues of the binding
loop. The NK-ethanethiol modi¢cation is not itself contained
in the binding loop, but in the adjacent sca¡old loop con-
nected to the binding loop by a disul¢de bridge through
Cys14 (Fig. 1c). It is intriguing that the local conformation
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of the binding residues has been perturbed as well as the
conformation of the residues nearest in sequence to the NK-
ethanethiol backbone modi¢cation. One explanation for these
observations is that the binding loop is subject to less con-
formational constraints by adjacent regions of the protein
molecule. This interpretation is consistent with the X-ray crys-
tal structure of BPTI, which indicated higher B-factors in the
binding loop (residues 8^13) region of the protein structure
[10]. We can con¢dently say that the structural di¡erences
between the native and disul¢de-engineered proteins are con-
¢ned to the sca¡old and binding loop regions. However, at
this point, we cannot say anything further about the structure
of the ((NK(CH2)2SH)Gly38)BPTI molecule itself based on
these data.
Clearly, the synthetic approach used to make the disul¢de-
engineered BPTI is a fruitful one. The ligation reaction re-
ported here using the NK-ethanethiol auxiliary functional
group has proven to be comparable to native chemical liga-
tion at Cys1, both in rate and yield as found in previous
model studies [7]. The protein generated by this chemistry
contained a NK-(ethanethiol)Gly38 replacing the native Cys38
at the ligation site. This N-substituted residue did not interfere
with protein folding or disul¢de formation and resulted in a
functional ‘disul¢de-engineered’ protein with a good biochem-
Fig. 6. (a) Enlarged area of 1H-2D-TOCSY NMR spectra (taken in 90% H2O, 10% D2O, pH adjusted to 4.6 with trace HCl) for reference
BPTI (top) and ((NK(CH2)2SH)Gly38)BPTI (bottom). The amide-CK crosspeak for Cys38 is not evident for the disul¢de-engineered variant be-
cause the amide proton for this residue has been replaced with the NK-ethanethiol auxiliary functional group. The marked di¡erence in chemi-
cal shift for the Tyr10 amide-CK crosspeak in ((NK(CH2)2SH)Gly38)BPTI compared to the native protein and the essentially unchanged posi-
tions for Thr32 ant Asn43 amide-CK crosspeaks are consistent with only a localized di¡erence in the structures of these two proteins. (b)
Amide-CK region of 1H-NMR 2D-TOCSY spectra (taken in 90% H2O, 10% D2O, pH adjusted to 4.6 with trace HCl) for reference BPTI (top)
and ((NK(CH2)2SH)Gly38)BPTI (bottom). Assignments are given for the reference protein. The chemical shifts for both proteins show a high
degree of identity, indicating a highly similar global structure. Di¡erences in chemical shifts are localized to residues near the site of the NK-
(ethanethiol)glycine38 in ((NK(CH2)2SH)Gly38)BPTI (denoted by arrows).
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ical activity and internal core structure similar to the native
BPTI.
The feasibility of auxiliary functional group ligation for the
synthesis of active backbone-engineered proteins has been
demonstrated by these results. NK-backbone modi¢cations
have previously proven their worth in the world of peptides
for enhancing solubility of polypeptides both on resin and in
solution [24,25] and as ‘peptoids’ (oligo(N-substituted gly-
cines)) [15,16], for inhibiting proteolytic degradation [15], di-
merization [16] and for enhancing peptide ligand a⁄nities [26].
The work reported here extends ‘peptoid’ chemistry to the
realm of backbone functionalized proteins. The introduction
of novel chemically reactive moieties into de¢ned sites in the
primary sequence, independently of side-chain considerations,
can be exploited for a wide range of other purposes including
site speci¢c labelling, development of new chemistry on a
protein sca¡old or immobilizing an active protein onto a solid
support in a controlled fashion.
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Fig. 7. Regions of the BPTI structure with identical (dark) or signif-
icantly di¡erent chemical shifts (light) between the residues in the
native and ((NK(CH2)2SH)Gly38)BPTI proteins. Gly37 was not as-
signed in the NMR data. The orientation of this ¢gure is identical
to that of Fig. 2.
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